Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

Abroad (travel likely)RecruitingPHASE1

Conditions

Non-Small Cell Lung Cancer · Chemotherapy · PD1 Antibody · Glutathione

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Rochester, United States · Rochester, United States

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Orange, United States · Skokie, United States

Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC

Non-Small Cell Lung Cancer · Advanced/Metastatic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Hinsdale, United States · New Lenox, United States